4 Analysts Assess Addus HomeCare: What You Need To Know

During the last three months, 4 analysts shared their evaluations of Addus HomeCare ADUS, revealing diverse outlooks from bullish to bearish.

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 3 1 0 0
Last 30D 0 1 0 0 0
1M Ago 0 1 1 0 0
2M Ago 0 0 0 0 0
3M Ago 0 1 0 0 0

Analysts have set 12-month price targets for Addus HomeCare, revealing an average target of $106.5, a high estimate of $118.00, and a low estimate of $88.00. Experiencing a 9.75% decline, the current average is now lower than the previous average price target of $118.00.

price target chart

Interpreting Analyst Ratings: A Closer Look

A clear picture of Addus HomeCare's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Michael Wiederhorn Oppenheimer Maintains Outperform $118.00 $118.00
Andrew Mok Barclays Announces Equal-Weight $88.00 -
Ben Hendrix RBC Capital Maintains Outperform $102.00 -
Michael Wiederhorn Oppenheimer Maintains Outperform $118.00 -

Key Insights:

  • Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Addus HomeCare. This offers insight into analysts' perspectives on the current state of the company.
  • Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Addus HomeCare compared to the broader market.
  • Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Addus HomeCare's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Addus HomeCare's market standing. Stay informed and make well-considered decisions with our Ratings Table.

Stay up to date on Addus HomeCare analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

About Addus HomeCare

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

Addus HomeCare's Financial Performance

Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.

Revenue Growth: Addus HomeCare's remarkable performance in 3 months is evident. As of 31 December, 2023, the company achieved an impressive revenue growth rate of 11.86%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.

Net Margin: Addus HomeCare's net margin is impressive, surpassing industry averages. With a net margin of 7.08%, the company demonstrates strong profitability and effective cost management.

Return on Equity (ROE): Addus HomeCare's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.81% ROE, the company effectively utilizes shareholder equity capital.

Return on Assets (ROA): Addus HomeCare's ROA excels beyond industry benchmarks, reaching 1.9%. This signifies efficient management of assets and strong financial health.

Debt Management: With a below-average debt-to-equity ratio of 0.25, Addus HomeCare adopts a prudent financial strategy, indicating a balanced approach to debt management.

The Core of Analyst Ratings: What Every Investor Should Know

Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.

Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!